nct02637284 bpc-157 trial status BPC-157, There are currently no published randomized controlled trials (RCTs) BPC-157 has already hit the

Summary ProHealth Longevity's BPC-157 supplement is presented as a premium option in the growing oral peptide market, featuring a single transparent ingredient at a disclosed 500 mcg dosage using the arginate salt form, triple third-party lab testing with available Certificates of Analysis, and the backing of a company with over 36 years in the supplement industry

BPC-157 is not approved by Health Canada or the FDA for human use and remains an experimental research compound

Helpful context before the funnel FormBlends Editorial Context Reviewed May 14, 2026 Complete BPC-157 dosage guide with protocols for oral, injection, and nasal

While its exact mechanism of action remains unclear, it is known to promote angiogenesis, thus enhancing oxygenation to tissues and accelerating healing processes

Pricing is not uniform across the catalog, though: individual peptides are competitively priced, while its multi-peptide blends sit at the premium end, so value depends on the specific compound